Invitation to presentation of Xbrane Biopharma’s interim report January – March, 2021 on May 6, 2021.

Corporate Information

English

IR

mfn-ci-other

News

Xbrane Biopharma AB invites to a teleconference for investors, analysts and media on May 6, 2021, at 10.00 a.m. CET. Xbrane will publish the company’s interim report January – March, 2021, on Thursday the 6th of May, 2021, at 8.00 a.m. CET.

Martin Åmark, CEO, and Anette Lindqvist, CFO/IR, will present the interim report for January – March 2021, followed by a Q&A session. The presentation will be in English. To attend, please follow the link or dial-in at one of the numbers below:

Web link:
https://edge.media-server.com/mmc/p/eq2kbejf

Standard international: +44 (0) 2071 928 338
UK (Local): +44 (0) 844 481 97 52
UK (Tollfree): 800 279 66 19

Sweden (Local): +46 (0) 856 618 467
Sweden (TollFree): 020 012 51 60

US (Local): +1 646 741 31 67
US (TollFree): +1 877 870 91 35

Confirmation Code: 516 34 48